Andrew Yi Zhang

Manager, Greater China

Greater China

Mr. Zhang has close to ten years experience in the China pharmaceutical and device industry. Prior to joining Burrill & Company, he was a brand manager of Sanofi-Aventis Pharmaceuticals China Co., Ltd. During his tenure at Sanofi-Aventis, he managed the marketing of Plavix (Clopidogrel) and contributed to the success of the product. Under his leadership, Plavix became the number one cardiovascular drug in China with 700 million RMB in sales with an average of 50% annual growth rate. Prior to Sanofi-Aventis, Mr. Zhang also served as brand manager at Healthvision Pharmaceuticals responsible for the promotion of Azep (Azelastine spray) in China, where he successfully introduced “DTC” campaign with significant increase in both target prescribers and their prescriptions. He also worked at 3M (China) Co. in the sales and product area.

Mr. Zhang holds a medical degree and a Master degree in Clinical Medicine from a joint program by Shanghai Fudan University and Shanghai Traditional Chinese Medicine University.